Timmi has over 24 years of pharmaceutical experience in sales and marketing of both branded
and generic products. In her varying roles, she has been involved in the development, launch and growth of brands in pain management, addiction medicine, neurology, oncology, infectious disease, autoimmune disease, fertility, respiratory and diagnostics.
Most recently, Timmi was the head of
sales for a diagnostics company, specializing in COVID-19, strep, influenza and various other infectious diseases at Versea Diagnostics. Prior to that,
she was the therapy strategy lead for emerging markets at OptumRx’s specialty pharmacy division, where she developed go-to-market strategies for
Amongst many roles, Timmi led the marketing team at Scilex Pharmaceuticals, launching their first commercial product and was
one of the founding members of Sentynl Therapeutics, where she re-launched a branded generic in the pain space and was instrumental in building
and training their sales force. Timmi overseas Sales Strategy and Development at Neo7Biosciences, managing the global market.